Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 228,684	$ 251,253
Prepaid expenses and other current assets	10,817	6,626
Deferred offering costs	128
Total current assets	239,629	257,879
Deferred lease asset	703	715
Property, plant and equipment, net	2,497	287
Total assets	242,829	258,881
Current liabilities
Accounts payable	4,083	1,994
Accrued expenses and other current liabilities	14,875	5,135
Total current liabilities	18,958	7,129
Other non-current liabilities	999	450
Total liabilities	19,957	7,579
Commitments and contingencies - Note 10
Stockholders' equity
Preferred stock, $0.00001 par value per share; 10,000,000 shares authorized and no shares issued and outstanding as of March 31, 2021 and December 31, 2020
Common stock, $0.00001 par value per share; 200,000,000 shares authorized and 37,761,435 issued and outstanding as of March 31, 2021 and December 31, 2020
Additional paid-in capital	316,022	312,428
Accumulated deficit	(93,150)	(61,126)
Total stockholders’ equity	222,872	251,302
Total liabilities and stockholders' equity	$ 242,829	$ 258,881